| Autor: |
Wang W; Department of Medicine, Rammelkamp Center for Research, Cleveland, OH, USA., Kansakar U; Department of Medicine, Rammelkamp Center for Research, Cleveland, OH, USA., Markovic V; Department of Medicine, Rammelkamp Center for Research, Cleveland, OH, USA., Wang B; Department of Medicine, Rammelkamp Center for Research, Cleveland, OH, USA.; Case Western Reserve University School of Medicine, Cleveland, OH, USA.; Case Comprehensive Cancer Center, Cleveland, OH, USA., Sossey-Alaoui K; Department of Medicine, Rammelkamp Center for Research, Cleveland, OH, USA. Kxs586@case.edu.; Case Western Reserve University School of Medicine, Cleveland, OH, USA. Kxs586@case.edu.; Case Comprehensive Cancer Center, Cleveland, OH, USA. Kxs586@case.edu. |
| Abstrakt: |
Both TGF-β and the PI3K-AKT signaling pathways are known activators of various intracellular pathways that regulate critical cellular functions, including cancer cell survival and proliferation. The interplay between these two oncogenic pathways plays a major role in promoting the initiation, growth, and progression of tumors, including breast cancers. The molecular underpinning of the inter-relationship between these pathways is, however, not fully understood, as is the role of WAVE3 phosphorylation in the regulation of tumor growth and progression. WAVE3 has been established as a major driver of the invasion-metastasis cascade in breast cancer and other tumors of epithelial origin. WAVE3 phosphorylation downstream of PI3K was also shown to regulate cell migration. Here we show that, in addition to PI3K, WAVE3 tyrosine phosphorylation can also be achieved downstream of TGF-β and EGF and that WAVE3 tyrosine phosphorylation is required for its oncogenic activity. Our in vitro analyses found loss of WAVE3 phosphorylation to significantly inhibit cell migration, as well as tumorsphere growth and invasion. In mouse models for breast cancer, loss of WAVE3 phosphorylation inhibited tumor growth of two aggressive breast cancer cell lines of triple-negative subtype. More importantly, we found that WAVE3 phosphorylation is also required for the activation of PI3K, TGF-β, and EGF signaling and their respective downstream effectors. Therefore, our study identified a novel function for WAVE3 in the regulation of breast cancer development and progression through the modulation of a positive feedback loop between WAVE3 and PI3K-TGF-β-EGF signaling pathways. |
